STAT3-IN-11 is a selective STAT3 inhibitor that suppresses phosphorylation at the STAT3 pTyr705 site, inhibits phosphorylation of downstream genes (Survivin and Mcl-1) without affecting upstream tyrosine kinases (Src and JAK2) or p-STAT1 expression, and induces cancer cell apoptosis; it holds promise for the discovery of STAT3 inhibitors and anticancer agents.